Mitochondrial control of nuclear apoptosis

Area of Science:

• Cell Biology
• Biochemistry
• Molecular Biology

Background:

• Programmed cell death (PCD) can occur in anucleate cells, suggesting a cytoplasmic pathway.
• Mitochondria play a role in apoptosis, with a decrease in mitochondrial transmembrane potential (Δψm) preceding nuclear events.
• This decrease may involve the opening of mitochondrial permeability transition (PT) pores.

Purpose of the Study:

• To provide direct evidence that mitochondrial PT is a critical early event in apoptosis.
• To investigate the role of mitochondrial PT in inducing nuclear apoptosis.
• To explore the mechanism by which Bcl-2 inhibits apoptosis.

Main Methods:

• Utilized a cell-free system with purified mitochondria and nuclei.
• Employed pharmacological agents to induce or inhibit mitochondrial PT.
• Investigated the effect of Bcl-2 localization and overexpression on mitochondrial PT.
• Assessed the impact of bongkreik acid and atractyloside on PT and apoptosis.

Main Results:

• Mitochondria undergoing PT were sufficient to induce chromatin condensation and DNA fragmentation in a cell-free system.
• Pharmacological induction of PT enhanced apoptosis, while its prevention inhibited it both in vitro and in vivo.
• Apoptotic cell mitochondria induced disintegration of isolated nuclei, unlike normal cell mitochondria.
• Bongkreik acid, an ANT ligand, inhibited PT and apoptosis induction.
• Bcl-2 localized to mitochondrial membranes inhibited PT and apoptosis, with hyperexpression abolishing PT induction.

Conclusions:

• Mitochondrial PT is a critical and early event in the apoptotic cascade.
• The opening of mitochondrial PT pores is a key trigger for nuclear apoptosis.
• Bcl-2 likely inhibits apoptosis by preventing mitochondrial PT.